Baxter International stock gains on cautious analyst tone
Published on 09/21/2026 at 17:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Baxter International stock (ISIN US0673431090) trades with a market cap of $11.8 billion, while Barchart says 15 analysts now give it a Hold consensus and a mean price target of $27. The same update puts implied upside at 18.4 percent.
Analysts stay cautious
According to Barchart on September 21, 2026, the consensus is Hold, the coverage count is 15 analysts and the average target is $27. That combination matters because the target implies 18.4 percent upside from current price levels, but the tone remains guarded.
Reuters lists Baxter International on September 21, 2026, and tags the stock as trading higher, giving the shares a live market backdrop for the day. The market-cap figure of $11.8 billion also keeps the stock in large-cap territory for US investors.
Market backdrop
The current setup puts the valuation question ahead of a simple momentum story. For investors, the key point is that the analyst mean target and the market-cap scale are both visible, but the consensus itself is still Hold.
What the chart says
At the latest snapshot, the stock is being priced against a $27 average target rather than a stronger buy case. That leaves 18.4 percent implied upside as the main quantified reference point in the current coverage.
Stock level
Baxter International stock is trading higher on September 21, 2026, with a market cap of $11.8 billion and a Hold consensus from 15 analysts. The current reference point is the $27 mean target, which implies 18.4 percent upside.
Baxter International stock at a glance
- Company: Baxter International Inc.
- ISIN: US0673431090
- Ticker: BAX
- Trading venue: NYSE
- Market capitalization: $11.8 billion
- Sector / Industry: Health Care / Health Care Equipment & Supplies
- Index membership: S&P 500
